Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis

Published:2018-05-03 Issue:5 Volume:13 Page:e0196361
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mendoza-Sanchez Jose^ORCID,Silva Federico,Rangel Lady,Jaramillo Linda,Mendoza Leidy,Garzon Jenny,Quiroga Andrea

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy;A Rubboli;World J Cardiol,2011

2. Dynamed. Thromboembolic prophylaxis in atrial fibrillation. In: Tipo de documento: DynaMiscSummary. 2017.

3. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation;JD Sandham;Clin Trials,2005

4. Dabigatran versus Warfarin in Patients with Atrial Fibrillation;WM Clark;N Engl J Med,2004

5. Apixaban versus Warfarin in Patients with Atrial Fibrillation;WM Clark;N Engl J Med,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review;Frontiers in Pharmacology;2024-04-24

2. A Case of Direct-Acting Oral Anticoagulant-Induced Intramural Colon Hematoma Successfully Treated by Laparoscopic Surgery;Cureus;2024-04-18

3. Benefit-risk assessment of traditional Chinese medicine preparations of sinomenine using multicriteria decision analysis (MCDA) for patients with rheumatoid arthritis;BMC Complementary Medicine and Therapies;2023-02-06

4. Gastrointestinal Bleeding Associated With Warfarin and Rivaroxaban Therapy in Atrial Fibrillation Cases with Concomitant Coagulopathy;Cardiovascular & Hematological Disorders-Drug Targets;2021-11-25

5. Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans;Frontiers in Pharmacology;2021-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3